Gvh-267 Jun 2026

In preclinical studies, GVH-267 has demonstrated significant anti-inflammatory and tissue-protective effects in models of inflammatory bowel disease, arthritis, and multiple sclerosis. For example, in a mouse model of colitis, GVH-267 treatment reduced inflammation and improved histological scores. Similarly, in a model of rheumatoid arthritis, GVH-267 decreased joint inflammation and cartilage destruction.

Please let me know if you want to add or modify anything. GVH-267

GVH-267, chemically known as N-[2-(4-fluorophenyl)-3-(4-methylpiperazin-1-yl)propyl]-N-(2-hydroxy-5-nitrophenyl)urea, is a complex molecule with a molecular weight of 542.55 g/mol. The synthesis of GVH-267 involves a multi-step process, starting with the reaction of 4-fluorophenylacetic acid with 4-methylpiperazine. The intermediate product is then coupled with 2-hydroxy-5-nitrophenylurea to yield GVH-267. In preclinical studies

You will find the GVH-267 integrated into several vital systems across various industries: and multiple sclerosis. For example